Over the last six months, Progressive’s shares have sunk to $205.11, producing a disappointing 16.5% loss - a stark contrast to the S&P 500’s 2.3% gain. This might have investors contemplating their ...

Despite flat home values, many homeowners are seeing a spike in property taxes because 2025 represented a “gap” year where ...

Join the millions and keep up with the stories shaping entrepreneurship. Sign up today.

Stocks that outperform the market usually share key traits such as rising sales, expanding margins, and increasing returns on ...

Most drivers assume their car insurance will cover them when it counts. But standard auto […] ...

Sri Lanka is currently in the vice grip of fear-driven ‘administrative inertia’, and this is proving to be a serious obstacle to economic recovery and a tangible barrier to the smooth functioning of ...

Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") announced today the company will present the latest findings on lecanemab (generic name, U.S. brand ...

Lecanemab is the result of a strategic research alliance between Eisai and BioArctic. It is a humanized immunoglobulin gamma (IgG1) monoclonal antibody directed against aggregated soluble (protofibril ...

The Progressive Corporation is rated Buy, driven by strong underwriting (84.4% combined ratio) and AI efficiency. Click to read my latest analysis of PGR stock.

Amid rising global energy concerns due to the West Asia conflict, the Union Petroleum Ministry on Friday said that the supply ...

TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the publication of data from a post hoc pooled analysis of the Phase 3 ULTIMATE I and II studies evaluating BRIUMVI® (ublituximab-xiiy) in people ...

Amy Danise is the former managing editor for the insurance section at Forbes Advisor, which encompasses auto, home, renters, life, pet, travel, health and small business insurance. She is a highly ...